BioPorto
1.24 DKK
+9.73 %
Less than 1K followers
BIOPOR
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioPorto
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.7 | 7.9 | 36.2 | 7.7 | 10.6 | 10.4 | 11.6 | 40.3 |
| EBITDA | -19.8 | -21.9 | -73.1 | -30.1 | -17.7 | -22.3 | -13.4 | -83.6 |
| EBIT | -21.6 | -21.3 | -75.5 | -30.8 | -18.3 | -23.0 | -14.0 | -86.1 |
| EBIT-% | -222.9 % | -269.7 % | -208.2 % | -401.6 % | -172.9 % | -221.0 % | -120.4 % | -213.7 % |
| Profit before taxes | -22.3 | -19.1 | -73.7 | -31.2 | -19.7 | -23.3 | -13.4 | -87.6 |
| Net income | -20.9 | -18.0 | -68.2 | -27.5 | -18.1 | -23.3 | -13.3 | -82.1 |